Medtronic to Release New Data on Advanced Hybrid Closed-Loop Systems and Extended-Wear Infusion SetDUBLIN, June 09, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association 80th scientific sessions virtual meeting, June 12-16, 2020. Medtronic will be participating in this year’s ADA virtual sessions with 16 data presentations, a symposium, a product theater, and a virtual exhibit. Though its diverse ADA offerings, Medtronic will showcase the company’s automated insulin pump systems, continuous glucose monitoring (CGM) systems, and extended-wear infusion set technology; meaningful outcomes and differentiated support offerings, such as telehealth capabilities and the company response to the COVID-19 pandemic.
Bay Street News